Comments: 0 | Likes: 1 | Current Price: ₹ 553.55
Sumitomo Chemical India Ltd
Q3FY23 Result Analysis
Performance Highlights –9MFY23
- At theindustry level, over all demand, particularly in the domestic market, was sluggish during the quarter, primarily as a result of a delay in sowing due to the extended monsoons and an increase in channel inventory as a result of as lower off take during the kharif season.The inventory levels were also high, as the level of pest infestation was relatively low.
- Domestic volume growth during the quarter were largely benign due to the challenging environment. However, the decline in demand was partially offset by improved price realization. Sharpe decline in revenue from fungiside segment resulted into modest topline growth.
- The export growth continues to remain robust, while there are some some sing of slowdonw in Latin America due to high channel inventory. Recent capacity expansion investments should help sustain this encouraging trend. The export business has witnessed growth of 39% YoY in 9MFY23.
- 4 insecticide, 1 fungicide, 1 metal phosphide and 3 PGR products launched during 9MFY23.
- The companies efforts to enhance their porduct mix, revamp our distribution reach and scaling up our capacities positions us to deliver consistent results in the future.
- The company is steps to boost growth in both domestic and international markets. In recent years, the company had prioritized filling the gap in thier portfolio, particular for certain crops and pests.
Q3FY23 and 9MFY23 Financial Performance
Revenue Breakup
---------------------------------------------------
Sumitomo's Company Overview
Manufacturing Facilities
Capex Plan
Focus on R&D
3 fully equipped, DSIR approved R&D labs located at Mumbai, Bhavnagar and Gajod capable of synthesis, technical product and formulation development
R&D Team comprises of 75+ qualified and dedicated engineers & scientists of which 10+ are PhDs with more than 15 years of Experience
25+ patents granted across various geographies; 9 applications filed.
Product Pipeline
R&D facilities to gain capability for creating new processes and new combinations using SCC Japan’s chemistries which would help improve production processes and efficiency.
Full Year Financial Highlights
I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Stocx Research Club). I have no business relationship with any company whose stock is mentioned in this article.
Sources of the data - Company's Investor Presentation and Press Release. Disclosure - This is not a recommendation
I am not a SEBI Registered individual/entity and the above research article is only for educational purpose and is never intended as trading/investment advice.
Articles
Comments
